1ly2: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1ly2.jpg|left|200px]]
[[Image:1ly2.jpg|left|200px]]


{{Structure
<!--
|PDB= 1ly2 |SIZE=350|CAPTION= <scene name='initialview01'>1ly2</scene>, resolution 1.80&Aring;
The line below this paragraph, containing "STRUCTURE_1ly2", creates the "Structure Box" on the page.
|SITE=
You may change the PDB parameter (which sets the PDB file loaded into the applet)
|LIGAND= <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
|ACTIVITY=  
or leave the SCENE parameter empty for the default display.
|GENE= CR2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
-->
|DOMAIN=
{{STRUCTURE_1ly2| PDB=1ly2  | SCENE= }}  
|RELATEDENTRY=
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1ly2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ly2 OCA], [http://www.ebi.ac.uk/pdbsum/1ly2 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1ly2 RCSB]</span>
}}


'''Crystal structure of unliganded human CD21 SCR1-SCR2 (Complement receptor type 2)'''
'''Crystal structure of unliganded human CD21 SCR1-SCR2 (Complement receptor type 2)'''
Line 32: Line 29:
[[Category: Sage, D R.]]
[[Category: Sage, D R.]]
[[Category: Stehle, T.]]
[[Category: Stehle, T.]]
[[Category: complement control protein]]
[[Category: Complement control protein]]
[[Category: complement receptor]]
[[Category: Complement receptor]]
[[Category: epstein barr virus]]
[[Category: Epstein barr virus]]
[[Category: regulator of complement activation]]
[[Category: Regulator of complement activation]]
[[Category: short consensus repeat]]
[[Category: Short consensus repeat]]
[[Category: viral receptor]]
[[Category: Viral receptor]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 00:24:42 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 22:08:46 2008''

Revision as of 21:24, 2 May 2008

File:1ly2.jpg

Template:STRUCTURE 1ly2

Crystal structure of unliganded human CD21 SCR1-SCR2 (Complement receptor type 2)


Overview

Human complement receptor type 2 (CD21) is the cellular receptor for Epstein-Barr virus (EBV), a human tumor virus. The N-terminal two short consensus repeats (SCR1-SCR2) of the receptor interact with the EBV glycoprotein gp350/220 and also with the natural CD21 ligand C3d. Here we present the crystal structure of the CD21 SCR1-SCR2 fragment in the absence of ligand and demonstrate that it is able to bind EBV. Based on a functional analysis of wild-type and mutant CD21 and molecular modeling, we identify a likely region for EBV attachment and demonstrate that this region is not involved in the interaction with C3d. A comparison with the previously determined structure of CD21 SCR1-SCR2 in complex with C3d shows that, in both cases, CD21 assumes compact V-shaped conformations. However, our analysis reveals a surprising degree of flexibility at the SCR1-SCR2 interface, suggesting interactions between the two domains are not specific. We present evidence that the V-shaped conformation is induced by deglycosylation of the protein, and that physiologic glycosylation of CD21 would result in a more extended conformation, perhaps with additional epitopes for C3d binding.

Disease

Known disease associated with this structure: Systemic lupus erythematosus, susceptibility to, 9 OMIM:[120650]

About this Structure

1LY2 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding., Prota AE, Sage DR, Stehle T, Fingeroth JD, Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10641-6. Epub 2002 Jul 16. PMID:12122212 Page seeded by OCA on Sat May 3 00:24:42 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA